2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Short and long-term psychosocial consequences of participating in a colorectal cancer screening programme: a matched longitudinal study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives

          To investigate the psychosocial consequences of receiving a false-positive (no abnormalities) result or being diagnosed with polyps compared with receiving a negative result in a colorectal cancer (CRC) screening programme.

          Design and setting

          This was a longitudinal study nested in the roll-out of the Danish CRC screening programme that targets all individuals aged 50–74 years.

          Participants

          In the inclusion period (April–September 2017), all positive screenees (n=1854) were consecutively enrolled and matched 2:1:1 on sex, age (±2 years), municipality and screening date with negative screenees (n=933) and individuals not yet invited to screening (n=933).

          Questionnaires were sent by mail to all eligible participants in Region Zealand, Denmark, after the screening result, 2 months and 12 months after the final result.

          Positive screenees who did not receive the follow-up procedure were excluded.

          Main outcome measures

          The primary outcomes were psychosocial consequences. Outcomes were measured with the CRC screening-specific questionnaire Consequences of screening in CRC with 11 outcomes after the screening result and with 21 outcomes at the two later assessments.

          Results

          After receiving the screening result, individuals with no abnormalities, low-risk and medium-risk and high-risk polyps scored significantly worse on 8 of 11 outcomes compared with the negative screenee group. At the 12-month follow-up, the differences were still significant in 8 of 21 outcomes (no abnormalities), 4 of 21 outcomes (low-risk polyps) and 10 of 21 outcomes (medium-risk and high-risk polyps). The negative screenee group and the group not yet invited to screening differed psychosocially on 5 of 11 outcomes after the screening result, but on none of the 21 outcomes at the 2 months and 12 months follow-up.

          Conclusions

          The study showed that there are both short-term and long-term psychosocial consequences associated with receiving a no abnormalities result or being diagnosed with polyps. The consequences were worst for individuals diagnosed with medium-risk and high-risk polyps.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: not found
          • Article: not found

          Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation

            The objective of this study was to develop a prospectively applicable method for classifying comorbid conditions which might alter the risk of mortality for use in longitudinal studies. A weighted index that takes into account the number and the seriousness of comorbid disease was developed in a cohort of 559 medical patients. The 1-yr mortality rates for the different scores were: "0", 12% (181); "1-2", 26% (225); "3-4", 52% (71); and "greater than or equal to 5", 85% (82). The index was tested for its ability to predict risk of death from comorbid disease in the second cohort of 685 patients during a 10-yr follow-up. The percent of patients who died of comorbid disease for the different scores were: "0", 8% (588); "1", 25% (54); "2", 48% (25); "greater than or equal to 3", 59% (18). With each increased level of the comorbidity index, there were stepwise increases in the cumulative mortality attributable to comorbid disease (log rank chi 2 = 165; p less than 0.0001). In this longer follow-up, age was also a predictor of mortality (p less than 0.001). The new index performed similarly to a previous system devised by Kaplan and Feinstein. The method of classifying comorbidity provides a simple, readily applicable and valid method of estimating risk of death from comorbid disease for use in longitudinal studies. Further work in larger populations is still required to refine the approach because the number of patients with any given condition in this study was relatively small.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Measurement of health status

                Bookmark

                Author and article information

                Journal
                BMJ Evid Based Med
                BMJ Evid Based Med
                ebmed
                ebm
                BMJ Evidence-Based Medicine
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                2515-446X
                2515-4478
                April 2022
                3 June 2021
                : 27
                : 2
                : 87-96
                Affiliations
                [1 ] departmentThe Research Unit for General Practice and Section of General Practice, Department of Public Health , University of Copenhagen , Kobenhavn, Denmark
                [2 ] Primary Health Care Research Unit , Region Zealand, Denmark
                Author notes
                [Correspondence to ] Dr Jessica Malmqvist, The Research Unit for General Practice and Section of General Practice, Department of Public Health, University of Copenhagen, Kobenhavn 1165, Denmark; jessica.malmqvist@ 123456sund.ku.dk
                Author information
                http://orcid.org/0000-0002-9299-4369
                http://orcid.org/0000-0001-8247-3642
                Article
                bmjebm-2020-111576
                10.1136/bmjebm-2020-111576
                8961773
                34083210
                161bd918-fff1-411b-b7b3-ef48c6cda930
                © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

                This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

                History
                : 20 May 2021
                Funding
                Funded by: Region Zealand Foundation;
                Award ID: 13-000849
                Award ID: 15-000342
                Categories
                Original Research
                1506
                Custom metadata
                unlocked

                evidence-based practice,primary healthcare,public health

                Comments

                Comment on this article